Close
Close

KLOW™ Peptide Therapy 3-Month Membership Program

4.9 Avg. Rating

1000+ Reviews

KLOW™ is a physician-supervised peptide protocol that combines Kisspeptin-10, PT-141 (Bremelanotide), and Oxytocin. Each peptide works through a different biological pathway involved in sexual desire, arousal, intimacy, and reproductive hormone signaling.
Rather than targeting blood flow alone, KLOW is designed to support the neurological, hormonal, and emotional components of sexual wellness. Treatment may be appropriate for both men and women experiencing changes in libido, intimacy, or sexual satisfaction after a comprehensive medical evaluation. Research into kisspeptin and oxytocin for sexual wellness remains ongoing.
Each peptide contributes through a unique mechanism: Kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal (HPG) axis, helping regulate the body’s natural release of reproductive hormones that influence sexual health and hormone production. PT-141 (Bremelanotide) activates melanocortin receptors within the central nervous system. Unlike medications that primarily improve blood flow, PT-141 acts on brain pathways involved in sexual desire and arousal. Oxytocin is a naturally occurring neuropeptide involved in social bonding, trust, emotional connection, and aspects of sexual response. It has been investigated for its potential role in enhancing intimacy and relationship satisfaction. Together, these peptides are intended to support multiple aspects of sexual wellness through complementary biological pathways.
Research has investigated these peptides for their potential to support:
  • Healthy sexual desire (libido)
  • Sexual arousal
  • Emotional intimacy and partner connection
  • Relationship satisfaction
  • Healthy reproductive hormone signaling
  • Sexual confidence
  • Overall sexual wellness
  • Improved quality of intimate relationships
Individual responses vary, and not every patient will experience all potential benefits.
Following a medical evaluation, KLOW may be considered for adults experiencing:
  • Low libido
  • Reduced sexual desire
  • Difficulty with arousal
  • Decreased intimacy
  • Hormonal changes affecting sexual wellness
  • Age-related changes in sexual function
  • Individuals seeking a comprehensive, physician-supervised approach to sexual wellness
Treatment recommendations are always individualized based on your medical history, current medications, and overall health.
Each component of KLOW has been investigated independently in human and preclinical research. PT-141 (bremelanotide) is the most extensively studied component. Research demonstrates that it works through central nervous system pathways rather than by increasing blood flow. Kisspeptin has shown promise in clinical research for activating reproductive hormone pathways and stimulating brain regions associated with sexual attraction and arousal. Researchers continue to investigate its potential applications in both men and women. Oxytocin has been studied for its effects on social bonding, emotional connection, trust, and aspects of sexual function. Results have been mixed, and additional research is needed to better define which patients may benefit most. Although the individual peptides have published research, studies evaluating the combination of Kisspeptin-10, PT-141, and Oxytocin together remain limited.
KLOW should only be used under the supervision of a licensed healthcare provider. Potential side effects vary depending on the peptide and may include:
  • Nausea
  • Facial flushing
  • Headache
  • Injection site irritation
  • Temporary increase in blood pressure
  • Fatigue
  • Dizziness
Certain medical conditions, cardiovascular disease, uncontrolled hypertension, pregnancy, or specific medications may make treatment inappropriate. Regular follow-up appointments allow your provider to monitor your response and adjust treatment as needed.

Is KLOW for men, women, or both?

Depending on your medical history and treatment goals, KLOW may be appropriate for both men and women following a provider evaluation.

Is this the same as Viagra® or Cialis®?

No. KLOW is designed to support the neurological, hormonal, and emotional aspects of sexual wellness. Traditional erectile dysfunction medications primarily improve blood flow.

How is treatment administered?

Depending on your personalized treatment plan, your provider may prescribe injectable or intranasal formulations when medically appropriate.

When can I expect results?

Some patients notice improvements within days to weeks, while others may require a longer treatment period. Individual responses vary.

Will KLOW increase my hormone levels?

Kisspeptin influences the body’s natural reproductive hormone signaling rather than directly supplying hormones. Your provider will determine whether hormone testing is appropriate.

Is laboratory testing required?

Your provider may recommend laboratory testing before or during treatment based on your medical history and overall treatment goals.
Every peptide treatment program includes:
  • Comprehensive medical history review
  • Telehealth consultation with a licensed medical provider
  • Personalized treatment recommendations
  • Prescription when medically appropriate
  • Individualized dosing guidance
  • Ongoing provider follow-up
  • Secure patient portal messaging
  • Educational resources and administration instructions
  • Medication sourced from licensed U.S. 503A compounding pharmacies when prescribed
  • Quality documentation, including Certificates of Analysis and sterility testing where applicable
Patients choose SevenHealth Medical because we provide individualized, evidence-informed care focused on safety and long-term wellness. Our approach includes:
  • Personalized treatment plans
  • Licensed U.S. medical providers
  • Comprehensive evaluations before prescribing
  • Ongoing monitoring throughout treatment
  • High-quality medications from licensed U.S. 503A compounding pharmacies
  • Transparent communication and patient education
  • Convenient telehealth appointments
  • Treatment plans tailored to each patient’s health goals
KLOW combines Kisspeptin-10, PT-141, and Oxytocin to target multiple aspects of sexual wellness, including hormone signaling, sexual desire, arousal, and emotional intimacy. Treatment begins with a comprehensive medical evaluation to determine whether therapy is appropriate for your individual needs. While PT-141 has established clinical evidence for specific indications, research on kisspeptin, oxytocin, and combination peptide protocols continues to evolve. At SevenHealth Medical, every treatment plan is individualized and supervised by a licensed healthcare provider to prioritize safety, informed decision-making, and personalized care.

Educational Disclaimer

This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Peptide therapy should only be used under the supervision of a licensed healthcare provider after an appropriate medical evaluation. Individual results may vary.

$100 OFF GLP-1 Injectable Plans for New Members ! CODE: